- Katie Davidson
Choose the health content that’s right for you, and get it delivered right in your inbox.
“With the recent increase of COVID-19 cases in our community and the severity of illness we are seeing in our hospitalized COVID patients, we are offering this treatment in hopes of lowering the numbers of hospitalized COVID patients and improving our patients’ symptoms and recovery from COVID-19.” said Anita Cornett, MD, Chief Medical Officer.
What are monoclonal antibodies (MAB) and how do they work?
Monoclonal antibodies are proteins that mimic the immune system’s ability to fight COVID-19 and are made in laboratories to help prevent infection.
Since our immune system relies on antibodies to detect and destroy harmful substances like viruses, monoclonal antibodies are doing the same thing but in a more controlled way, flagging and blocking harmful infections from entering our cells — COVID-19, in this case.
What are the treatments like?
AdventHealth Manchester’s MAB treatments of REGEN-COV are given by intravenous infusion (through your veins). It’s an outpatient procedure for referred patients who tested positive for COVID-19 and are at high risk of developing a more serious case of coronavirus.
Who is eligible for treatments?
MAB infusions should be used for patients 12 and older with an active, mild-to moderate COVID-19 case, who are at risk of progressing to a severe case that would lead to hospitalization. This includes anyone with the following conditions:
♦ Cardiovascular disease
♦ Chronic kidney disease
♦ Chronic lung disease
♦ Diabetes
♦ High blood pressure
♦ Immunosuppressive disease or treatment
♦ Medical-related technological dependence
♦ Neurodevelopmental disorders
♦ Pregnancy
♦ Obesity
♦ Older age (65 and older)
♦ Sickle cell disease
♦ Other medical conditions or factors
If you think you or a loved one might be a candidate for MAB treatments at AdventHealth Manchester, talk to your primary care provider. If your doctor thinks you’re at risk of progressing, you should be referred immediately and start the infusion as soon as possible. No visitors are allowed with patients in the MAB infusion clinic at this time, but wheelchair assistance can be provided.
For more information on these treatments or anything related to COVID-19, visit CoronavirusResourceHub.com.
Recent News
Lake Mary Little League®, home of the 2024 Little League® World Series Champions, is proud to announce a new partnership with AdventHealth.
Every year, the American Heart Association recognizes programs that perform exceptionally in the area of stroke. We are proud to announce AdventHealth Avista, AdventHealth Littleton, AdventHealth...
Dr. Matthew Villani, a foot and ankle surgeon with AdventHealth Medical Group located at AdventHealth Waterman, addresses foot and ankle injuries.
AdventHealth Millenia ER is celebrating its first anniversary of providing lifesaving, whole-person care to residents and visitors in West Orlando.
Anesthesia Associates of Kansas City becomes a strategic partner for the rapidly growing hospital in south Overland Park.
UChicago Medicine AdventHealth Hinsdale now offers life-saving stroke care with a new minimally invasive procedure, improving survival rates and quality of life.
The hospital’s three-story expansion will be completed in summer 2026.
AdventHealth Zephyrhills is leading the way in Pasco County with a new treatment for clostridioides difficile or C. diff.
AdventHealth is proud to introduce you to Frannette Miller, BSN, RN, winner of our DAISY Award for the ray of light she shines on the lives of her patients every day in the Behavioral Health Unit at...
Dr. Jason Jennings, orthopedic surgeon with AdventHealth Medical Group Colorado Joint Replacement at Porter, was selected to present his research findings at the 3rd International Consensus Meeting on...
When it comes to back health, how you sleep matters just as much as how you move during the day. According to Dr. Sharad Rajpal, a neurosurgeon at AdventHealth Avista, your nighttime habits can either...
July marks Fibroid Awareness Month—a time to spotlight a condition that affects an estimated 26 million women across the United States.